Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 3/20 | 0.43 |
| ▸ | STAT1 | P42224 | 2/20 | 0.43 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.43 |
| ▸ | RELA | Q04206 | 2/20 | 0.43 |
| ▸ | EDNRB | P24530 | 3/20 | 0.43 |
| ▸ | EDNRA | P25101 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cinnamosmolide SCHEMBL21025700 | 1.00 | NFKB1 (0.43) | NFKB1STAT1NFKB2RELAEDNRB | |
| Cinnamosmolide SCHEMBL21025571 | 1.00 | NFKB1 (0.43) | NFKB1STAT1NFKB2RELAEDNRB | |
| Cinnamosmolide SCHEMBL15557098 | 1.00 | NFKB1 (0.43) | NFKB1STAT1NFKB2RELAEDNRB | |
| Pereniporin B SCHEMBL21025895 | 0.81 | NFKB1 (0.34) | NFKB1STAT1NFKB2RELAEDNRB | |
| Cinnamodial SCHEMBL15557354 | 0.70 | EDNRB (0.41) | NFKB1STAT1NFKB2RELAEDNRB | |
| Cinnamodial SCHEMBL20462860 | 0.70 | EDNRB (0.41) | NFKB1STAT1NFKB2RELAEDNRB | |
| SCHEMBL21025894 | 0.69 | EDNRB (0.47) | NFKB1STAT1NFKB2RELAEDNRB | |
| SCHEMBL21025698 | 0.68 | EDNRB (0.44) | NFKB1STAT1NFKB2RELAEDNRB | |
| Ugandensolide SCHEMBL21025899 | 0.60 | MAPK1 (0.31) | NFKB1STAT1NFKB2RELAEDNRB | |
| SCHEMBL14982984 | 0.59 | CYP3A4 (0.37) | NFKB1NFKB2RELAMAPK1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-11946083-B2 | Method for the microbial production of specific natural capsaicinoids | CONAGEN INC. (US) | 2024-04-02 | — | — | US | claimed |
| US-20230012268-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-01-12 | — | — | US | claimed |
| US-20220403427-A1 | METHOD FOR THE MICROBIAL PRODUCTION OF SPECIFIC NATURAL CAPSAICINOIDS | CONAGEN INC. (US) | 2022-12-22 | — | — | US | claimed |
| EP-4072558-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-10-19 | — | — | EP | claimed |
| US-20220233463-A1 | LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2022-07-28 | — | — | US | claimed |
| EP-4017486-A1 | COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY ANANDAMIDE DEFICIENCY AND USES THEREOF | Buzzelet Development And Technologies Ltd (IL) | 2022-06-29 | — | — | EP | claimed |
| US-20220168246-A1 | COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY ANANDAMIDE DEFICIENCY AND USES THEREOF | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2022-06-02 | — | — | US | claimed |
| EP-3968970-A1 | LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-03-23 | — | — | EP | claimed |
| EP-4683527-A1 | VAPORIZABLE ALKALOID COMPOSITIONS AND METHODS OF USE THEREOF | Ready Mix Naturals, LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| US-20250388533-A1 | PRODRUGS OF PHENOLIC TRPV1 AGONISTS | CONCENTRIC ANALGESICS INC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-12-16 | — | — | US | disclosed |
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | disclosed |
| US-20250312298-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PAIN USING CAPSAICIN | ANKURA TRUST COMPANY, LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT | 2025-10-09 | — | — | US | disclosed |
| EP-4017486-A1 | COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY ANANDAMIDE DEFICIENCY AND USES THEREOF | Buzzelet Development And Technologies Ltd (IL) | 2022-06-29 | — | — | EP | disclosed |
| US-20220168246-A1 | COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY ANANDAMIDE DEFICIENCY AND USES THEREOF | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2022-06-02 | — | — | US | disclosed |
| US-11344516-B2 | Stable aqueous capsaicin injectable formulations and medical uses thereof | CENTREXION THERAPEUTICS CORPORATION (US) | 2022-05-31 | — | — | US | disclosed |
| US-20220112165-A1 | PEGYLATED PRODRUGS OF PHENOLIC TRPV1 AGONISTS | Concentric Analgesics, Inc. | 2022-04-14 | — | — | US | disclosed |
| EP-3968970-A1 | LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-03-23 | — | — | EP | disclosed |
| US-20190150437-A1 | USE OF SESQUITERPENES AND THEIR ANALOGS AS GREEN INSECTICIDES FOR CONTROLLING DISEASE VECTORS AND PLANT PESTS | OHIO STATE INNOVATION FOUNDATION | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250312298-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PAIN USING CAPSAICIN | TRPV1, TRPV4, TRPV5 | NFKB1 1524/4885STAT1 2827/4885NFKB2 2058/4885 |
| US-20250388533-A1 | PRODRUGS OF PHENOLIC TRPV1 AGONISTS | TRPV1, TRPV3, TRPV4 | NFKB1 3181/4885STAT1 4059/4885NFKB2 2932/4885 |
| US-20190150437-A1 | USE OF SESQUITERPENES AND THEIR ANALOGS AS GREEN INSECTICIDES FOR CONTROLLING DISEASE VECTORS AND PLANT PESTS | NOTUM, DDT, CYP51A1 | NFKB1 3371/4885STAT1 3609/4885NFKB2 3832/4885 |
| US-11344516-B2 | Stable aqueous capsaicin injectable formulations and medical uses thereof | IL15, TRPV1, TRPV5 | NFKB1 163/4885STAT1 2310/4885NFKB2 1103/4885 |
| US-20220112165-A1 | PEGYLATED PRODRUGS OF PHENOLIC TRPV1 AGONISTS | TRPV1, TRPV4, TRPV3 | NFKB1 1822/4885STAT1 1947/4885NFKB2 1750/4885 |
| US-20220403427-A1 | METHOD FOR THE MICROBIAL PRODUCTION OF SPECIFIC NATURAL CAPSAICINOIDS | TRPV1, CYP51A1, NAAA | NFKB1 2811/4885STAT1 4394/4885NFKB2 3019/4885 |
| US-12497381-B2 | Vaporizable alkaloid compositions and methods of use thereof | CHRM5, NNMT, CHRM1 | NFKB1 4606/4885STAT1 4339/4885NFKB2 4806/4885 |
| US-11946083-B2 | Method for the microbial production of specific natural capsaicinoids | TRPV1, CYP51A1, NAAA | NFKB1 2811/4885STAT1 4394/4885NFKB2 3019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.